We've found
184,457
clinical trials
Oncology Clinical Trial
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
ESRD Clinical Trial
Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
The SNORES Randomized Clinical Trial
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
The SNORES Randomized Clinical Trial
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Impact of Daylight on Patients With Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma Clinical Trial
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma Clinical Trial
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma Clinical Trial
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Hodgkin's Lymphoma Clinical Trial
A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
BIPOLAR DISORDER Clinical Trial
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Status: Enrolling,
Phase
IV
Updated: 1/6/2016
Click here to add this to my saved trials
BIPOLAR DISORDER Clinical Trial
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Status: Enrolling,
Phase
IV
Updated: 1/6/2016
Click here to add this to my saved trials
BIPOLAR DISORDER Clinical Trial
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Status: Enrolling,
Phase
IV
Updated: 1/6/2016
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
A Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
PTSD Clinical Trial
Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
Status: Enrolling,
Phase
II
Updated: 1/4/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
Status: Enrolling,
Phase
I
Updated: 1/4/2016
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Mindfulness for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gout Clinical Trial
Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling,
Phase
I
Updated: 1/6/2016
Click here to add this to my saved trials
Meningiomas Clinical Trial
A Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Knee Injury Clinical Trial
Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials
Cirrhosis Clinical Trial
Breath and Blood Ammonia Response to an Oral Protein Challenge
Status: Enrolling
Updated: 2/8/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Spinal Cord Injury Clinical Trial
Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
Status: Enrolling,
Phase
III
Updated: 7/12/2016
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Repeat Emergency Department Visits Among Patients With Asthma and COPD
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Rheumatology Clinical Trial
Surgical Weight-Loss to Improve Functional Status Trajectories Following Total Knee Arthroplasty (SWIFT Trial)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer
Status: Enrolling
Updated: 10/16/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Perturbing of HIV Reservoir With Immune Stimulation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
B Precursor Type Acute Leukemia Clinical Trial
Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling,
Phase
II
Updated: 11/3/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling,
Phase
II
Updated: 11/3/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling,
Phase
II
Updated: 11/3/2017
Click here to add this to my saved trials
Periodontitis Clinical Trial
IL29 and IL28B Variants Associated With Periodontal Disease Pathogenesis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Congenital Diaphragmatic Hernia Clinical Trial
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Kidney Stones Clinical Trial
Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Healing Hearts and Mending Minds in Older Adults Living With HIV
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Sickle Cell Anemia Clinical Trial
The Role of Endothelin-1 in Sickle Cell Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Solid Tumors and Hematologic Malignancy Clinical Trial
An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumors and Hematologic Malignancy Clinical Trial
An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Body Composition and White Adipose Tissue Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatric Issue Clinical Trial
Self Reported Level of Agitation of Patients Presenting to an Emergency Department
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Advancing Symptom Alleviation With Palliative Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1/2 Study of In Situ Vaccination With Tremelimumab and IV Durvalumab Plus PolyICLC in Subjects With Advanced, Measurable, Biopsy-accessible Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
ESRD Clinical Trial
Updated: 1/4/2016
Bringing Care to Patients: Patient-Centered Medical Home for Kidney Disease
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 3/14/2016
The SNORES Randomized Clinical Trial
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 3/14/2016
The SNORES Randomized Clinical Trial
Status: Enrolling
Updated: 3/14/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
Impact of Daylight on Patients With Acute Myocardial Infarction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma Clinical Trial
Updated: 12/31/1969
A Study of Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase 1 Study of the EZH2 Inhibitor Tazemetostat in Pediatric Subjects With Relapsed or Refractory INI1-Negative Tumors or Synovial Sarcoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Non-Hodgkin's Lymphoma Clinical Trial
Updated: 12/31/1969
A Study of Obinutuzumab, Rituximab, Polatuzumab Vedotin, and Venetoclax in Relapsed or Refractory Follicular Lymphoma (FL) or Diffuse Large B-Cell Lymphoma (DLBCL)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
BIPOLAR DISORDER Clinical Trial
Updated: 1/6/2016
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Status: Enrolling,
Phase
IV
Updated: 1/6/2016
Click here to add this to my saved trials
BIPOLAR DISORDER Clinical Trial
Updated: 1/6/2016
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Status: Enrolling,
Phase
IV
Updated: 1/6/2016
Click here to add this to my saved trials
BIPOLAR DISORDER Clinical Trial
Updated: 1/6/2016
DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolar 1 Disorder
Status: Enrolling,
Phase
IV
Updated: 1/6/2016
Click here to add this to my saved trials
Metastatic Melanoma Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
PTSD Clinical Trial
Updated: 12/31/1969
Reflective Function as a Mediator of Interpersonal Psychotherapy (IPT)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 1/4/2016
Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
Status: Enrolling,
Phase
II
Updated: 1/4/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Updated: 1/4/2016
Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)
Status: Enrolling,
Phase
I
Updated: 1/4/2016
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Mindfulness for Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gout Clinical Trial
Updated: 1/6/2016
Safety and Pharmacodynamics of SEL-212 (Pegsiticase + SEL-110) in Subjects With Elevated Blood Uric Acid Levels
Status: Enrolling,
Phase
I
Updated: 1/6/2016
Click here to add this to my saved trials
Meningiomas Clinical Trial
Updated: 12/31/1969
A Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Knee Injury Clinical Trial
Updated: 4/4/2018
Needleless Jet Injected (J-Tip) Lidocaine in Children Undergoing Regional Anesthesia Prior to Knee Arthroscopy
Status: Enrolling
Updated: 4/4/2018
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Updated: 12/31/1969
A Study of the ReCor Medical Paradise System in Clinical Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 10/24/2017
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
Status: Enrolling,
Phase
IV
Updated: 10/24/2017
Click here to add this to my saved trials
Cirrhosis Clinical Trial
Updated: 2/8/2016
Breath and Blood Ammonia Response to an Oral Protein Challenge
Status: Enrolling
Updated: 2/8/2016
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Study of RXDX-101 in Children With Recurrent or Refractory Solid Tumors and Primary CNS Tumors, With or Without TRK, ROS1, or ALK Fusions
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Spinal Cord Injury Clinical Trial
Updated: 1/8/2016
Recovery of Cardiovascular Function With Epidural Stimulation After Human Spinal Cord Injury
Status: Enrolling
Updated: 1/8/2016
Click here to add this to my saved trials
Immunology / Infectious Diseases, Nephrology / Urology Clinical Trial
Updated: 7/12/2016
A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis (AP)
Status: Enrolling,
Phase
III
Updated: 7/12/2016
Click here to add this to my saved trials
Pulmonary / Respiratory Diseases Clinical Trial
Updated: 1/7/2016
Repeat Emergency Department Visits Among Patients With Asthma and COPD
Status: Enrolling
Updated: 1/7/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Primary Immunodeficiency Diseases (PID) Clinical Trial
Updated: 12/31/1969
Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Rheumatology Clinical Trial
Updated: 12/31/1969
Surgical Weight-Loss to Improve Functional Status Trajectories Following Total Knee Arthroplasty (SWIFT Trial)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 10/16/2017
Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer
Status: Enrolling
Updated: 10/16/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Perturbing of HIV Reservoir With Immune Stimulation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
B Precursor Type Acute Leukemia Clinical Trial
Updated: 12/31/1969
Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2017
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling,
Phase
II
Updated: 11/3/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2017
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling,
Phase
II
Updated: 11/3/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/3/2017
Genetic Predictors of Benefit to Pembrolizumab
Status: Enrolling,
Phase
II
Updated: 11/3/2017
Click here to add this to my saved trials
Periodontitis Clinical Trial
Updated: 12/31/1969
IL29 and IL28B Variants Associated With Periodontal Disease Pathogenesis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Congenital Diaphragmatic Hernia Clinical Trial
Updated: 12/31/1969
Fetoscopic Endoluminal Tracheal Occlusion (FETO) for Severe Left Diaphragmatic Hernia (CDH)
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Kidney Stones Clinical Trial
Updated: 3/16/2016
Night Time Use of Thiazide Diuretics for Improved Reduction in Stone Risk in Stone Formers With Elevated Urine Calcium
Status: Enrolling
Updated: 3/16/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
Healing Hearts and Mending Minds in Older Adults Living With HIV
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Sickle Cell Anemia Clinical Trial
Updated: 12/31/1969
The Role of Endothelin-1 in Sickle Cell Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 8/24/2017
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 8/24/2017
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 8/24/2017
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Updated: 8/24/2017
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
Status: Enrolling,
Phase
II
Updated: 8/24/2017
Click here to add this to my saved trials
Solid Tumors and Hematologic Malignancy Clinical Trial
Updated: 12/31/1969
An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Solid Tumors and Hematologic Malignancy Clinical Trial
Updated: 12/31/1969
An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Body Composition and White Adipose Tissue Inflammation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatric Issue Clinical Trial
Updated: 3/21/2017
Self Reported Level of Agitation of Patients Presenting to an Emergency Department
Status: Enrolling
Updated: 3/21/2017
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Advancing Symptom Alleviation With Palliative Treatment
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials